20th Annual Mount Sinai Inflammatory Bowel Disease Consultants Course: State of the Art Management

Friday, February 28, 2025, 7:00 AM - 4:00 PM, Leon & Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY


The 20th Annual Mount Sinai Inflammatory Bowel Disease Consultant’s Course will provide an in-depth review of strategies for participants to better diagnose, classify and achieve remission in patients with Inflammatory Bowel Diseases. State-of-the-art lectures will be given by expert faculty on optimizing therapies, innovative treatment, and epidemiology of IBD. This onsite activity and live webinar will include panel discussions, discuss the positioning of new medications, and provide an opportunity for attendees to present their own questions and challenging clinical scenarios. The goal is to meet the needs of our IBD patients by addressing sub-optimal disease control, preventable disease complications, and the potential negative consequences of therapy, such as serious infections and cancer.

1. Describe the use and positioning of new medications approved for the treatment of IBD.
2. Describe treatment options for special populations including pregnant patients and patients with penetrating sequelae.
3. Describe appropriate implementation of therapeutic drug monitoring and treat-to-target approaches in clinical practice.
4. Identify the rationale for positioning of biologic therapies for Crohn’s disease and ulcerative colitis.

Physicians $125.00
Allied Health Professionals $100.00
Residents & Fellows Complimentary 

Cancellation Policy
All refund and cancellation requests must be emailed to the CME office at [email protected] by February 14, 2025. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal to or less than $50.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Friday, February 28, 2025